Literature DB >> 34999248

Can exercise training teach us how to treat Alzheimer's disease?

Aleksi M Huuha1, Cecilie S Norevik1, José Bianco N Moreira2, Asgeir Kobro-Flatmoen3, Nathan Scrimgeour2, Miia Kivipelto4, Henriette Van Praag5, Maryam Ziaei6, Sigrid Botne Sando7, Ulrik Wisløff8, Atefe R Tari9.   

Abstract

Alzheimer's disease (AD) is the most common cause of dementia and there is currently no cure. Novel approaches to treat AD and curb the rapidly increasing worldwide prevalence and costs of dementia are needed. Physical inactivity is a significant modifiable risk factor for AD, estimated to contribute to 12.7% of AD cases worldwide. Exercise interventions in humans and animals have shown beneficial effects of exercise on brain plasticity and cognitive functions. In animal studies, exercise also improved AD pathology. The mechanisms underlying these effects of exercise seem to be associated mainly with exercise performance or cardiorespiratory fitness. In addition, exercise-induced molecules of peripheral origin seem to play an important role. Since exercise affects the whole body, there likely is no single therapeutic target that could mimic all the benefits of exercise. However, systemic strategies may be a viable means to convey broad therapeutic effects in AD patients. Here, we review the potential of physical activity and exercise training in AD prevention and treatment, shining light on recently discovered underlying mechanisms and concluding with a view on future development of exercise-free treatment strategies for AD.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34999248     DOI: 10.1016/j.arr.2022.101559

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  2 in total

1.  Temporal changes in personal activity intelligence and the risk of incident dementia and dementia related mortality: A prospective cohort study (HUNT).

Authors:  Atefe R Tari; Geir Selbæk; Barry A Franklin; Sverre Bergh; Håvard Skjellegrind; Robert E Sallis; Ingunn Bosnes; Eystein Stordal; Maryam Ziaei; Stian Lydersen; Asgeir Kobro-Flatmoen; Aleksi M Huuha; Javaid Nauman; Ulrik Wisløff
Journal:  EClinicalMedicine       Date:  2022-08-18

2.  An examination of the relationship among plasma brain derived neurotropic factor, peripheral vascular function, and body composition with cognition in midlife African Americans/Black individuals.

Authors:  Miranda K Traylor; Allison J Bauman; Napatsorn Saiyasit; Carl A Frizell; Benjamin D Hill; Amy R Nelson; Joshua L Keller
Journal:  Front Aging Neurosci       Date:  2022-08-25       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.